Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166906 · ClinicalTrials.gov registry record
Pain Blocking During Drug Administration or Blood Collection With Needles
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 53
- Enrollment target
NCT01166906: Completed study, sponsored by University of California, Irvine.
NCT01166906 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01166906 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
There is a gating mechanism in the dorsal horn of the spinal cord that acts to facilitate or inhibit transmission of pain signals to the brain. The gate can be closed by mechanical stimuli such as touch and vibration.
Primary Outcome
Pain Blocking During Drug Administration or Blood Collection With Needles
Interventions
- DEVICE pain blocking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2010-03 |
| Est. Completion | 2014-03 |
What the finished NCT01166906 record still lists
NCT01166906 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which pain blocking is the first listed.
NCT01166906 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01166906 about?
NCT01166906 is a clinical study titled "Pain Blocking During Drug Administration or Blood Collection With Needles". There is a gating mechanism in the dorsal horn of the spinal cord that acts to facilitate or inhibit transmission of pain signals to the brain. The gate can be closed by mechanical stimuli such as touch and vibration.
What is the current status of trial NCT01166906?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2010-03. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01166906?
The interventions under investigation include: pain blocking (DEVICE).
Who is sponsoring clinical trial NCT01166906?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia